Alice Massacci1, Eleonora Sperandio2, Lorenzo D'Ambrosio3, Mariano Maffei4, Fabio Palombo1, Luigi Aurisicchio1, Gennaro Ciliberto5, Matteo Pallocca6. 1. Takis srl, Rome, Italy. 2. Biostatistics, Bioinformatics and Clinical Trial Center, IRCCS Regina Elena National Cancer Institute, Rome, Italy. 3. Tumor Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy. 4. EvviVax srl, Rome, Italy. 5. Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy. 6. Biostatistics, Bioinformatics and Clinical Trial Center, IRCCS Regina Elena National Cancer Institute, Rome, Italy. matteo.pallocca@ifo.gov.it.
Abstract
BACKGROUND: Tracking the genetic variability of Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) is a crucial challenge. Mainly to identify target sequences in order to generate robust vaccines and neutralizing monoclonal antibodies, but also to track viral genetic temporal and geographic evolution and to mine for variants associated with reduced or increased disease severity. Several online tools and bioinformatic phylogenetic analyses have been released, but the main interest lies in the Spike protein, which is the pivotal element of current vaccine design, and in the Receptor Binding Domain, that accounts for most of the neutralizing the antibody activity. METHODS: Here, we present an open-source bioinformatic protocol, and a web portal focused on SARS-CoV-2 single mutations and minimal consensus sequence building as a companion vaccine design tool. Furthermore, we provide immunogenomic analyses to understand the impact of the most frequent RBD variations. RESULTS: Results on the whole GISAID sequence dataset at the time of the writing (October 2020) reveals an emerging mutation, S477N, located on the central part of the Spike protein Receptor Binding Domain, the Receptor Binding Motif. Immunogenomic analyses revealed some variation in mutated epitope MHC compatibility, T-cell recognition, and B-cell epitope probability for most frequent human HLAs. CONCLUSIONS: This work provides a framework able to track down SARS-CoV-2 genomic variability.
BACKGROUND: Tracking the genetic variability of Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) is a crucial challenge. Mainly to identify target sequences in order to generate robust vaccines and neutralizing monoclonal antibodies, but also to track viral genetic temporal and geographic evolution and to mine for variants associated with reduced or increased disease severity. Several online tools and bioinformatic phylogenetic analyses have been released, but the main interest lies in the Spike protein, which is the pivotal element of current vaccine design, and in the Receptor Binding Domain, that accounts for most of the neutralizing the antibody activity. METHODS: Here, we present an open-source bioinformatic protocol, and a web portal focused on SARS-CoV-2 single mutations and minimal consensus sequence building as a companion vaccine design tool. Furthermore, we provide immunogenomic analyses to understand the impact of the most frequent RBD variations. RESULTS: Results on the whole GISAID sequence dataset at the time of the writing (October 2020) reveals an emerging mutation, S477N, located on the central part of the Spike protein Receptor Binding Domain, the Receptor Binding Motif. Immunogenomic analyses revealed some variation in mutated epitope MHC compatibility, T-cell recognition, and B-cell epitope probability for most frequent human HLAs. CONCLUSIONS: This work provides a framework able to track down SARS-CoV-2 genomic variability.
Authors: Guillaume Marçais; Arthur L Delcher; Adam M Phillippy; Rachel Coston; Steven L Salzberg; Aleksey Zimin Journal: PLoS Comput Biol Date: 2018-01-26 Impact factor: 4.475
Authors: Priyank Shukla; Preeti Pandey; Bodhayan Prasad; Tony Robinson; Rituraj Purohit; Leon G D'Cruz; Murtaza M Tambuwala; Ankur Mutreja; Jim Harkin; Taranjit Singh Rai; Elaine K Murray; David S Gibson; Anthony J Bjourson Journal: Brief Bioinform Date: 2022-01-17 Impact factor: 11.622
Authors: Matthew R Chang; Luke Tomasovic; Natalia A Kuzmina; Adam J Ronk; Patrick O Byrne; Rebecca Johnson; Nadia Storm; Eduardo Olmedillas; Yixuan J Hou; Alexandra Schäfer; Sarah R Leist; Longping V Tse; Hanzhong Ke; Christian Coherd; Katrina Nguyen; Maliwan Kamkaew; Anna Honko; Quan Zhu; Galit Alter; Erica Ollmann Saphire; Jason S McLellan; Anthony Griffiths; Ralph S Baric; Alexander Bukreyev; Wayne A Marasco Journal: Nat Commun Date: 2022-10-03 Impact factor: 17.694